261 related articles for article (PubMed ID: 7050498)
1. Changes in clonal expression during the course of acute leukemia: possible subsets in childhood leukemia.
Hann HW; Nowell PC; Koch P; Minowada J; Leitmeyer JE; August CS
J Natl Cancer Inst; 1982 Aug; 69(2):393-9. PubMed ID: 7050498
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte surface receptors in childhood acute lymphocytic leukemia.
Esber E; DiNicola W; Movassaghi N; Leikin S
Pediatrics; 1975 Nov; 56(5):788-92. PubMed ID: 1081671
[TBL] [Abstract][Full Text] [Related]
4. B cell markers in Ph1-positive acute lymphoblastic leukemia.
Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
6. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
Forbes IJ; Zalewski PD; Valente L; Gee D
Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
[TBL] [Abstract][Full Text] [Related]
7. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
8. Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation.
Testoni N; Martinelli G; Zaccaria A; Miggiano MC; Pelliconi S; Visani G; Manfroi S; Gherlinzoni F; Mangianti S; Tura S
Bone Marrow Transplant; 1996 Dec; 18(6):1141-5. PubMed ID: 8971385
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
10. Surface membrane determinants on childhood acute lymphocytic leukemia cells: immunoglobulin, Fc and C3 receptors.
Esber EC; Movassaghi N; Leikin SL
Clin Exp Immunol; 1978 Jun; 32(3):523-30. PubMed ID: 278686
[TBL] [Abstract][Full Text] [Related]
11. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
12. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
Aisenberg AC; Wilkes BM
Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
[TBL] [Abstract][Full Text] [Related]
13. Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report.
Preis PP; Zielinski CC; Linkesch W; Bettelheim P; Radaskiewicz T; Pavelka M; Haas O; Aiginger P
Wien Klin Wochenschr; 1988 May; 100(10):331-6. PubMed ID: 3261061
[TBL] [Abstract][Full Text] [Related]
14. Clonal chromosome changes in stimulated lymphocytes of untreated human B-cell leukemias.
Sadamori N; Han T; Minowada J; Matsui S; Sandberg AA
Cancer Res; 1983 Jul; 43(7):3287-91. PubMed ID: 6850637
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
16. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
17. Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16).
Kohno S; Minowada J; Sandberg AA
J Natl Cancer Inst; 1980 Mar; 64(3):485-93. PubMed ID: 6928235
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
19. [Is leukemic transformation of donor cells possible?].
Vinogradova OA; Savchenko VG; Domracheva EV; Parovichnikova EN; Diachenko LV; Alimova GA; Mendeleeva LP; Liubimova LS; Sokolov AN; Zhelnova EI; Pokrovskaia OS
Ter Arkh; 2004; 76(7):28-34. PubMed ID: 15379124
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
